Name: #100: Opening Plenary and Keynote Address: From Personal Journeys to Global Solutions – Collaborating for Innovation and Patient Impact
Start: 2025-06-16T08:00:00-0400
End: 2025-06-16T10:00:00-0400

Monday June 16, 2025 8:00am - 10:00am EDT

Ballroom

Component Type: Forum

Start your day with a powerful and inspiring session that brings together visionary leaders, groundbreaking science, and real-world patient experiences. DIA President and CEO Marwan Fathallah sets the stage, followed by a moving personal story from Jimi Olaghere, who shares his extraordinary journey from a sickle cell diagnosis to conquering Mt. Kilimanjaro. Dive into the future of innovative treatments with a keynote on Type 1 Diabetes breakthroughs by renowned researcher Douglas Melton. The session concludes with a dynamic multi-stakeholder panel, where top regulators, researchers, and industry leaders explore how global collaboration can accelerate patient-centered innovation and derisk product development.

Learning Objectives

Describe how patient experiences and personal journeys can inform and inspire innovative approaches to drug development and healthcare solutions; Analyze the scientific and regulatory challenges associated with developing innovative treatments for chronic and rare diseases, such as Type 1 Diabetes and Sickle Cell Anemia; Identify collaborative strategies that enable multi-stakeholder partnerships to derisk medical product development and accelerate patient access to innovative therapies.

Chair

Marwan Fathallah, MBA, MSc

Speaker

Panelist
Emer Cooke, MBA, MSc

Panelist
Sudip Parikh, PhD

The Patient Experience
Jimi Olaghere

The Future of Innovative Treatments
Doug Melton, PhD

Panelist
Martin Makary, MD, MPH

Panelist
Lawrence Tallon

Speakers

Emer Cooke

Chair, ICMRA; Executive Director, European Medicines Agency, Netherlands

Ms Cooke is Executive Director of the EMA and Chair of ICMRA. Starting her mandate as ED in June 2020 amid a public health crisis of unprecedented scale she announced “My number one priority will be to drive forward EMA’s response to the pandemic and the work already ongoing to... Read More →

Marwan Fathallah

President & Chief Executive Officer, DIA, United States

Prior to joining DIA in 2023, Fathallah was the Operating Officer and EVP at Ortho Clinical Diagnostics, accountable for Operations, Post Market Product Science and Engineering, Regulatory, Quality, Medical, Clinical, Scientific Affairs, and Process Excellence. Before joining Ortho... Read More →

Martin Makary

Commissioner, FDA, United States

Doug Melton

Distinguished Research Fellow, Vertex, United States

Jimi Olaghere

Patient Advocate, United States

Jimi Olaghere is a CasGevy recipient who has developed a keen interest in the advancements of Cell and Gene therapies, since his transformative participation in the groundbreaking clinical trial. He is passionate about the positive impact these therapies can have on patients in need... Read More →

Sudip Parikh

Chief Executive Officer and Executive Publisher, Science Journals, United States

Sudip S. Parikh, PhD, serves as Senior Vice President and Managing Director for DIA Americas. He previously served as Vice President and General Manager of Health & Consumer Solutions at Battelle, leading its Healthcare Improvement, Public Health Research, and Consumer, Industrial... Read More →

Lawrence Tallon

Chief Executive Officer, Medicines and Healthcare products Regulatory Agency, United Kingdom

Monday June 16, 2025 8:00am - 10:00am EDT
Ballroom Walter E. Washington Convention Center 801 Allen Y. Lew Place, NW Washington, DC 20001-3614 USA

00: Plenary, Forum

format csv
Tags Forum

Need help? View Support Guides
Event questions? Contact Event Planner

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!